PortfoliosLab logoPortfoliosLab logo
ELV vs. COR
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ELV vs. COR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Elevance Health Inc (ELV) and Cencora Inc. (COR). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ELV achieves a 16.45% return, which is significantly higher than COR's -16.27% return. Over the past 10 years, ELV has underperformed COR with an annualized return of 13.53%, while COR has yielded a comparatively higher 17.47% annualized return.


ELV

1D
1.23%
1M
1.52%
YTD
16.45%
6M
13.69%
1Y
6.82%
3Y*
-3.25%
5Y*
2.49%
10Y*
13.53%

COR

1D
0.07%
1M
10.42%
YTD
-16.27%
6M
-18.27%
1Y
-3.81%
3Y*
17.14%
5Y*
20.65%
10Y*
17.47%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ELV vs. COR - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ELV
Elevance Health Inc
16.45%-3.14%-20.72%-6.89%11.83%46.12%7.74%16.33%18.11%58.72%
COR
Cencora Inc.
-16.27%51.48%10.37%25.33%26.26%44.09%23.37%23.51%-17.57%19.51%

Correlation

The correlation between ELV and COR is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.16

Correlation (3Y)
Calculated over the trailing 3-year period

0.29

Correlation (5Y)
Calculated over the trailing 5-year period

0.40

Correlation (10Y)
Calculated over the trailing 10-year period

0.39

Correlation (All Time)
Calculated using the full available price history since Oct 30, 2001

0.38

Over the past year, the correlation between ELV and COR has dropped to 0.16 - well below their long-term average of 0.38, suggesting their price drivers have been diverging.

Fundamentals

Market Cap

ELV:

$89.06B

COR:

$55.03B

EPS

ELV:

$23.46

COR:

$13.07

PE Ratio

ELV:

17.22

COR:

21.55

PS Ratio

ELV:

0.45

COR:

0.17

PB Ratio

ELV:

2.03

COR:

16.20

Total Revenue (TTM)

ELV:

$200.42B

COR:

$328.68B

Gross Profit (TTM)

ELV:

$46.43B

COR:

$11.66B

EBITDA (TTM)

ELV:

$8.92B

COR:

$3.64B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ELV vs. COR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ELV
ELV Risk / Return Rank: 4747
Overall Rank
ELV Sharpe Ratio Rank: 4949
Sharpe Ratio Rank
ELV Sortino Ratio Rank: 4343
Sortino Ratio Rank
ELV Omega Ratio Rank: 4545
Omega Ratio Rank
ELV Calmar Ratio Rank: 4949
Calmar Ratio Rank
ELV Martin Ratio Rank: 4747
Martin Ratio Rank

COR
COR Risk / Return Rank: 3636
Overall Rank
COR Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
COR Sortino Ratio Rank: 3333
Sortino Ratio Rank
COR Omega Ratio Rank: 3333
Omega Ratio Rank
COR Calmar Ratio Rank: 3939
Calmar Ratio Rank
COR Martin Ratio Rank: 3737
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ELV vs. COR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Elevance Health Inc (ELV) and Cencora Inc. (COR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ELVCORDifference
Sharpe ratioReturn per unit of total volatility

+0.30

Sortino ratioReturn per unit of downside risk

+0.43

Omega ratioGain probability vs. loss probability

1.07

1.01

+0.07

Calmar ratioReturn relative to maximum drawdown

0.22

-0.12

+0.34

Martin ratioReturn relative to average drawdown

0.41

-0.33

+0.73

ELV vs. COR - Sharpe Ratio Comparison

The current ELV Sharpe Ratio is 0.18, which is higher than the COR Sharpe Ratio of -0.13. The chart below compares the historical Sharpe Ratios of ELV and COR, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ELV vs. COR - Drawdown Comparison

The maximum ELV drawdown since its inception was -67.19%, smaller than the maximum COR drawdown of -71.01%. Use the drawdown chart below to compare losses from any high point for ELV and COR.


Loading charts...

Drawdown Indicators


ELVCORDifference

Max Drawdown

Largest peak-to-trough decline

-67.19%

-71.01%

+3.82%

Max Drawdown (1Y)

Largest decline over 1 year

-30.60%

-32.44%

+1.84%

Max Drawdown (3Y)

Largest decline over 3 years

-50.38%

-32.44%

-17.94%

Max Drawdown (5Y)

Largest decline over 5 years

-50.38%

-32.44%

-17.94%

Max Drawdown (10Y)

Largest decline over 10 years

-50.38%

-32.44%

-17.94%

Current Drawdown

Current decline from peak

-25.47%

-24.54%

-0.93%

Average Drawdown

Average peak-to-trough decline

-15.29%

-13.62%

-1.67%

Ulcer Index

Depth and duration of drawdowns from previous peaks

16.75%

11.68%

+5.07%

Volatility

ELV vs. COR - Volatility Comparison

Elevance Health Inc (ELV) has a higher volatility of 9.29% compared to Cencora Inc. (COR) at 6.51%. This indicates that ELV's price experiences larger fluctuations and is considered to be riskier than COR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ELVCORDifference

Volatility (1M)

Calculated over the trailing 1-month period

9.29%

6.51%

+2.78%

Volatility (6M)

Calculated over the trailing 6-month period

27.54%

26.93%

+0.61%

Volatility (1Y)

Calculated over the trailing 1-year period

38.79%

30.20%

+8.59%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

29.00%

22.30%

+6.70%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

30.86%

27.48%

+3.38%

Dividends

ELV vs. COR - Dividend Comparison

ELV's dividend yield for the trailing twelve months is around 1.70%, more than COR's 0.83% yield.


PositionTTM20252024202320222021202020192018201720162015
COR
Cencora Inc.
0.83%0.67%0.93%0.96%1.13%5.13%6.74%7.48%2.07%1.61%1.77%1.17%
ELV
Elevance Health Inc
1.70%1.95%1.77%1.26%1.00%0.98%1.18%1.06%1.14%1.20%1.81%1.79%

Financials

ELV vs. COR - Financials Comparison

This section allows you to compare key financial metrics between Elevance Health Inc and Cencora Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


30.00B40.00B50.00B60.00B70.00B80.00B90.00B20222023202420252026
50.18B
78.36B
(ELV) Total Revenue
(COR) Total Revenue
Values in USD except per share items

ELV vs. COR - Profitability Comparison

The chart below illustrates the profitability comparison between Elevance Health Inc and Cencora Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

5.0%10.0%15.0%20.0%25.0%30.0%20222023202420252026
18.1%
4.6%
Portfolio components
ELV - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Elevance Health Inc reported a gross profit of 9.10B and revenue of 50.18B. Therefore, the gross margin over that period was 18.1%.

COR - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Cencora Inc. reported a gross profit of 3.59B and revenue of 78.36B. Therefore, the gross margin over that period was 4.6%.

ELV - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Elevance Health Inc reported an operating income of 2.66B and revenue of 50.18B, resulting in an operating margin of 5.3%.

COR - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Cencora Inc. reported an operating income of 1.14B and revenue of 78.36B, resulting in an operating margin of 1.5%.

ELV - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Elevance Health Inc reported a net income of 1.76B and revenue of 50.18B, resulting in a net margin of 3.5%.

COR - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Cencora Inc. reported a net income of 1.64B and revenue of 78.36B, resulting in a net margin of 2.1%.


Frequently Asked Questions


ELV and COR have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ELV has higher volatility (9.29%) compared to COR (6.51%). In terms of maximum drawdown, ELV dropped -67.19% vs COR's -71.01%.

ELV currently has the higher Sharpe Ratio (0.18 vs -0.13), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ELV and COR

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer